Today
Heart failure affects about 7.7 million American adults.1 Renova is focused on the subpopulation of patients with heart failure with reduced ejection fraction (HFrEF), where roughly 40% die within five years.2
Guideline-directed medical therapy has meaningfully improved survival, but substantial risk remains: once a patient is hospitalized for heart failure, five-year mortality approaches 75%.2 That residual risk is the gap Renova is working to close.
- 1 American Heart Association, 2026 Heart Disease and Stroke Statistics Update (7.7 million U.S. adults, 2021–2023 data).
- 2 Gorodeski EZ et al. HF STATS 2026: An Updated Report on Heart Failure Epidemiology and Outcomes from the Heart Failure Society of America. Journal of Cardiac Failure, 2026.









